Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oestrogen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00702858
What this trial is testing

Trial of Blue Citrus Compared to Placebo in Patients Receiving Aromatase Inhibitor Therapy for Estrogen Receptor Positive Post-Menopausal Breast Cancer

Who this might be right for
Breast CancerJoint Pain
Legacy Health System 30
Testing effectiveness (Phase 2)Looking for participantsNCT06366347
What this trial is testing

ALPINE: Maintenance Letrozole/Abemaciclib

Who this might be right for
Endometrial CancerRecurrent Endometrial CancerTP53
Dana-Farber Cancer Institute 32
Not applicableStudy completedNCT00700232
What this trial is testing

ABCB4 Gene Mutations in Intrahepatic Cholestasis of Pregnancy and Controls

Who this might be right for
Intrahepatic Cholestasis of Pregnancy
University Hospital, Tours 120
Not applicableStudy completedNCT06908941
What this trial is testing

The Cardiovascular Benefits of Resistance Training and Dark Chocolate in Female Adults

Who this might be right for
Vascular Function in Healthy Volunteers
National Cheng Kung University 31
Testing effectiveness (Phase 2)UnknownNCT01266213
What this trial is testing

Fulvestrant (F)/Goserelin (G) vs Anastrozole (A)/G vs G for Premenopausal Women

Who this might be right for
Metastatic Breast CancerEstrogen Receptor Positive TumorBreast Cancer Nos Premenopausal
Samsung Medical Center 147
Testing effectiveness (Phase 2)Study completedNCT00001848
What this trial is testing

The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by Endometriosis

Who this might be right for
EndometriosisPelvic Pain
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 612
Large-scale testing (Phase 3)Study completedNCT00000420
What this trial is testing

Safety of Estrogens in Lupus: Birth Control Pills

Who this might be right for
Systemic Lupus Erythematosus
NYU Langone Health 350
Post-approval studies (Phase 4)Study completedNCT00649090
What this trial is testing

Evaluate the Safety of Adjuvant Treatment With Exemestane Following Previous Treatment With Tamoxifen in Postmenopausal Women With Estrogen Sensitive Primary Breast Cancer

Who this might be right for
Breast Neoplasms
Pfizer 1,549
Not applicableStudy completedNCT05392985
What this trial is testing

Detection and Analysis of MBC With Heterogeneous ER Expression

Who this might be right for
Breast Cancer
Fudan University 51
Large-scale testing (Phase 3)Study completedNCT00004650
What this trial is testing

Phase III Randomized Study of the Effect of Postmenopausal Estrogen Replacement Therapy on Alveolar Bone Loss

Who this might be right for
Osteoporosis
National Institute of Dental and Craniofacial Research (NIDCR) 150
Testing effectiveness (Phase 2)Looking for participantsNCT05916196
What this trial is testing

[18F]FES PET/.CT in Uterine Cancer

Who this might be right for
Uterine Cancer
Abramson Cancer Center at Penn Medicine 30
Early research (Phase 1)Study completedNCT00318318
What this trial is testing

Beneficial Effects of Oral Premarin Estrogen Replacement Therapy Assessed by Human Genome Array

Who this might be right for
HealthyEstrogen Replacement Therapy
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 20
Early research (Phase 1)WithdrawnNCT01320787
What this trial is testing

18-F-Fluoroacetate as PET Imaging Agent

Who this might be right for
Brain CancerBreast CancerProstate Cancer
M.D. Anderson Cancer Center
Large-scale testing (Phase 3)Study completedNCT00256698
What this trial is testing

Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy

Who this might be right for
Breast Cancer
AstraZeneca 514
Testing effectiveness (Phase 2)Ended earlyNCT04190056
What this trial is testing

Pembrolizumab and Tamoxifen With or Without Vorinostat for the Treatment of Estrogen Receptor Positive Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Prognostic Stage IV Breast Cancer AJCC v8
University of California, San Francisco 1
Early research (Phase 1)Study completedNCT02392611
What this trial is testing

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Alobresib (Formerly GS-5829) in Adults With Advanced Solid Tumors and Lymphomas and in Combination With Exemestane or Fulvestrant in Adults With Estrogen Receptor Positive Breast Cancer

Who this might be right for
Solid Tumors and Lymphomas
Gilead Sciences 33
Post-approval studies (Phase 4)Study completedNCT05469204
What this trial is testing

Effect of Estrogen Treatment on Drug Metabolism and Transport

Who this might be right for
Transgender Persons
University of Washington 22
Testing effectiveness (Phase 2)Study completedNCT03703492
What this trial is testing

Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS

Who this might be right for
Breast CancerDuctal Carcinoma in Situ - Category
University of Wisconsin, Madison 12
Very early researchStudy completedNCT01916122
What this trial is testing

Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor Status

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 54
Testing effectiveness (Phase 2)Ended earlyNCT00210028
What this trial is testing

Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Neoplasms
Institut Claudius Regaud 40
Next Page